CP 86325 sodium salt
Modify Date: 2024-01-04 20:23:48
CP 86325 sodium salt structure
|
Common Name | CP 86325 sodium salt | ||
|---|---|---|---|---|
| CAS Number | 149904-87-0 | Molecular Weight | 442.46300 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C23H19N2NaO4S | Melting Point | N/A | |
| MSDS | Chinese USA | Flash Point | N/A | |
Use of CP 86325 sodium saltDarglitazone Sodium, a thiazolidinedione, is an orally active, potent, and selective PPAR-γ (peroxisome proliferator-activated receptor) agonist. Darglitazone Sodium is effective in controlling blood glucose and lipid metabolism, and can be used for type II diabetes research[1][2]. |
| Name | sodium,5-[[4-[3-(5-methyl-2-phenyl-1,3-oxazol-4-yl)propanoyl]phenyl]methyl]-1,3-thiazolidin-3-ide-2,4-dione |
|---|---|
| Synonym | More Synonyms |
| Description | Darglitazone Sodium, a thiazolidinedione, is an orally active, potent, and selective PPAR-γ (peroxisome proliferator-activated receptor) agonist. Darglitazone Sodium is effective in controlling blood glucose and lipid metabolism, and can be used for type II diabetes research[1][2]. |
|---|---|
| Related Catalog | |
| Target |
PPAR-γ |
| References |
| Molecular Formula | C23H19N2NaO4S |
|---|---|
| Molecular Weight | 442.46300 |
| Exact Mass | 442.09600 |
| PSA | 120.89000 |
| LogP | 4.50800 |
| RIDADR | NONH for all modes of transport |
|---|
| Darglitazone sodium salt |
| DARGLITAZONE SODIUM |
| UNII-A1P35HS4XI |
| CP-86,325-2 |